Bain Capital Life Sciences Discloses Position in CARA / Cara Therapeutics
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that Bain Capital Life Sciences Opportunities III, LP has filed a 13G form with the SEC disclosing ownership of 2,696,030 shares of Cara Therapeutics Inc (CARA). This represents 5.0% of the company.Cara Therapeutics is a clinical-stage biopharmaceutical company foc
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-89739213-33fa62bb8fd14c5b98e1ae20e7c0b58b.jpg "3 Surprising Stocks That Have Outperformed Big Names in the Last 10 Years")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1632178785-2bbf98c928b749329959617a646e8bf8.jpg "How WhatsApp Makes Money")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1132012708-0d3f8f4b04c14405aa72e54940ab6a0e-3064dc565912458a94297c60b3d609e7.jpg "Is a Career in Investment Banking Worth It?")
:max_bytes(150000):strip_icc():format(jpeg)/KraftCadburyHostileTakeover-56143341d0004032a1cdb65ec3c2859b.jpg "What Are Some Top Examples of Hostile Takeovers?")
